Rallybio Corp (RLYB) support and resistance · rev $212.0K
Rallybio Corp (RLYB) is a biotechnology company listed on US.
This page maps Rallybio Corp (RLYB) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported RLYB revenue for 2026-06-30 was $212.0K. Net income was $35.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RLYB currently screens at market cap $13.8M.
RLYB currently screens at market cap $13.8M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new RLYB 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the RLYB quote page for the session range and the stock page for the full model.
Not investment advice.